Nexalin Technology (NXL) Operating Income (2021 - 2026)
Nexalin Technology (NXL) recorded quarterly Operating Income of -$2.1 million in Q1 2026, up 12.15% quarter-over-quarter from -$2.4 million in Q4 2025, and down 5.4% on a YoY basis from -$2.2 million in Q1 2025.
Nexalin Technology (NXL) Operating Income (2021 - 2026) Analysis & Trends
Nexalin Technology's Operating Income history runs 6 years deep, the most recent figure standing at -$2.1 million for Q1 2026.
- In Q1 2026, Operating Income fell 5.4% year-over-year to -$2.1 million; the TTM figure through Mar 2026 stood at -$8.5 million (up 2.22% YoY), while the FY2025 annual figure was -$8.4 million, down 8.2% from the prior year.
- Operating Income was -$2.1 million for Q1 2026 at Nexalin Technology, up from -$2.4 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$293194.0 in Q3 2022 to a low of -$2.9 million in Q4 2024.
- Historically, Operating Income has averaged -$1.5 million across 5 years, with a median of -$1.6 million in 2025.
- The sharpest annual moves came in 2022 and 2023: Operating Income jumped 83.67% in 2022, then tumbled 723.87% in 2023.
- A 5-year view of Operating Income shows it stood at -$719617.0 in 2022, then tumbled by 125.74% to -$1.6 million in 2023, then tumbled by 77.0% to -$2.9 million in 2024, then gained by 16.08% to -$2.4 million in 2025, then gained by 12.15% to -$2.1 million in 2026.
- The last three Operating Income figures came in at -$2.1 million (Q1 2026), -$2.4 million (Q4 2025), and -$2.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.46 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 282.15 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 255.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 316.80 Mn |
| 10 | Nexalin Technology | 7.82 Mn | 5.11 Mn | 13,133.00 | -2.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.12 Mn |
| Dec 31, 2025 | -2.41 Mn |
| Sep 30, 2025 | -2.35 Mn |
| Jun 30, 2025 | -1.62 Mn |
| Mar 31, 2025 | -2.01 Mn |
| Dec 31, 2024 | -2.88 Mn |
| Sep 30, 2024 | -2.51 Mn |
| Jun 30, 2024 | -1.30 Mn |
| Mar 31, 2024 | -1.07 Mn |
| Dec 31, 2023 | -1.62 Mn |
| Sep 30, 2023 | -2.42 Mn |
| Jun 30, 2023 | -876,860.00 |
| Mar 31, 2023 | -779,426.00 |
| Dec 31, 2022 | -719,617.00 |
| Sep 30, 2022 | -293,194.00 |
| Jun 30, 2022 | -445,103.00 |
| Mar 31, 2022 | -375,117.00 |
| Dec 31, 2021 | -577,489.00 |
| Sep 30, 2021 | -1.80 Mn |